Maria Parker, None;
Andreas Lauer, Accreditation Council for Graduate Medical Education (R), Allergan (F), American Board of Ophthalmology (S), Clearside Biomedical (F), Genentech (F), NIH/NEI (F), Oxford BioMedica (F);
Tim Stout, Oxford Biomedica (F), Oxford Biomedica (C);
Mark Pennesi, AGTC (C), AGTC (S), Astellas Pharmaceuticals (C), Biogen (C), Editas (C), FFB (S), Gensight (C), IONIS Pharmaceuticals (C), Nacuity Pharmaceuticals (C), NightstaRX (S), Ophthotech (C), ProQR Therapeutics (C), RegenexBio (C), Sanofi (S), Sparks Therapeutics (C);
Paul Yang, FFB (F);
David Wilson, None;
Dongseok Choi, None;
Laura Erker, None;
Brandon Lujan, BioTime (C), Cell Cure Neurosciences (C), Genentech/Roche (R), Optovue (F), UC Berkeley (P), Zeiss (F), Zeiss (R);
Ou Tan, Optovue (F), Optovue (P);
Pierre-Olivier Barale, None;
Caroline Cohen, Sanofi (E);
Saddek Mohand-Said, None;
Isabelle Audo, None;
Jose Sahel, Banque publique d'Investissement (F), Choroideremia Research Foundation (S), Chronocam (I), Chronolife (I), ERC Synergy "HELMHOLTZ" (F), FFB (F), FFB (S), Fondation NRJ de l’Institut de France (S), Fovea pharmaceuticals (S), Genesignal (C), GenSight Biologics (I), GenSight Biologics (C), LabEx LIFESENSES (F), Pixium Vision (I), Pixium Vision (C), Scientific Advisory Board of the Paris Region (S), Sparing Vision (I), Steering Committee of the European Vision Institute (S), Steering Committee of the French Translational Research Program in Health (S), Tilak Healthcare (I), Vision Medicines Member of the Strategic Committee of the City of Paris (S);
Richard Weleber, AGTC (S), AGTC (C), FFB (R), FFB (S), OHSU (P), Sanofi (C)